Background: Essential tremor (ET) is the most common tremor disorder. In addition to its hallmark feature, kinetic tremor of the upper limbs, patients may have
Introduction
Essential tremor (ET) is the most common tremor disorder among adults. 1 Although ET has long been regarded as a monosymptomatic benign movement disorder primarily characterized by kinetic tremor of the upper limbs, a range of additional motor and non-motor features has been described. Among the non-motor symptoms and signs (NMS) that have been described are cognitive impairment, depression, apathy, anxiety, personality characteristics, olfactory deficits, hearing problems, and sleep disturbances. 2, 3 There is evidence to suggest that most of the NMS observed in ET are not just epiphenomena, rather they are parts of the primary disease process. 4 In this backdrop, the question that is thought provoking and the answer to which remains largely elusive is what does appear first in ET: tremor or the NMS? Other movement disorders in which NMS are frequently present and substantially worsen the health-related quality of life are Parkinson's disease (PD) and Huntington's disease (HD). In PD, certain NMS such as rapid eye movement sleep behavior disorder (RBD), depression, and olfactory dysfunction may antedate the onset of motor symptoms by decades. 5, 6 Similarly patients with HD may have behavioral and/or cognitive problems long before the onset of motor symptoms. 7, 8 Considering the availability of robust evidence regarding the occurrence of these NMS before the onset of motor symptoms, the concept of a premotor stage is now well established in PD and HD. However, even though patients with ET can be burdened with several NMS, there has been no discussion as to whether there is a premotor phase in ET. It is important to review the evidence for the existence of a premotor phase in ET. Such a study could provide further insights into the neurobiological underpinnings of ET and establish the foundation for pre-clinical trials. Evidence indicating that some of the NMS may appear before the onset of tremor in patients with ET would favor the existence of a premotor phase in ET. In this article, we comprehensively review the evidence for the presence of a premotor phase in ET, and discuss plausible biological explanations and implications.
Methodology
In May 2017, the authors used PubMed to search for the relevant literature using the term ''essential tremor'' with additional search terms being ''premotor'', ''prodromal'', ''non-motor'', ''cognition'', ''memory'', ''depression'', ''apathy'', ''anxiety'', ''sleep'', ''olfaction'', ''hearing'', and ''personality''. This search yielded 773 articles (Table 1, Figure 1 ). Figure 1 ). In total, 65 articles pertinent to this topic were included for this review (Table 1, Figure 1 ).
Evidence suggesting presence of a premotor phase of ET
Cognitive dysfunction and the incidence of ET
Cognitive dysfunction in patients with ET has been reported in several case-control studies and deficits have been documented in several cognitive domains including attention, memory, visuospatial functions, and executive functions. 9, 10 With the exception of one longitudinal study (Neurological Disorders in Central Spain: NEDICES cohort), all others have compared cognitive function of prevalent ET cases with healthy controls (i.e., case-control studies). 11 Owing to their cross-sectional design, these studies were therefore not able to evaluate whether cognitive impairment occurred prior to the onset of tremor in ET. In NEDICES, a longitudinal cognitive evaluation was performed in three groups of elderly subjects aged 65 years and older (premotor ET, prevalent ET, and controls). 11 The premotor ET group comprised patients who were apparently normal at baseline and developed ET during the follow up (mean baseline age: 73.0¡5.7 years) (i.e., they had incident ET at follow up) whereas the prevalent ET group comprised patients who already had a diagnosis of ET at baseline (mean baseline age: 73.6¡6.3 years). The controls did not have a diagnosis of ET either at baseline or during follow up (mean baseline age: 72.4¡5.8 years). Interestingly, the premotor ET group performed more poorly than controls on the baseline 37-item Mini Mental Status Examination (37-MMSE). 11 Furthermore, the change in the 37-MMSE from baseline to first follow up (i.e., the rate of cognitive decline over a mean of 3.4¡0.5 years) was greater in the premotor ET group than the controls. Although 37-MMSE is a screening instrument that provides insight into global cognitive function and is not a detailed cognitive test, these data suggest that subtle cognitive dysfunction in ET may precede the motor signs, and that cognitive function seems to be declining at a more rapid rate than in age-matched controls.
In another set of longitudinal analyses from the same data set, the NEDICES investigators explored the effects of baseline education on risk of incident dementia in premotor ET and prevalent ET groups.
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There was a differential effect of education on the risk of incident dementia in premotor and prevalent ET; thus, 16.7% of premotor ET patients with lower education (i.e., less than or equal to primary education) developed incident dementia vs. 3.3% of premotor ET patients with higher education (i.e., greater or equal to secondary education). Interestingly, this difference in risk of incident dementia was not observed in prevalent ET patients with lower vs. higher education. The data suggested the presence of a protective effect of education against dementia in premotor ET but not in prevalent ET patients. The authors interpreted their results as follows: as the pathological changes related to dementia in ET are presumed to be gradual and slowly progressive in nature, it is possible that these changes occurred before the onset of tremor in the incident ET cases and the protective effect of education was probably effective only up to a certain threshold of neurodegeneration.
Depression and incidence ET
Depression has commonly been reported in patients with ET 13, 14 and in ET has also been noted to be associated with embarrassment and poor health-related quality of life. 15, 16 As discussed above, patients with other movement disorders, including PD and HD, note the presence of depression prior to the onset of motor symptoms. However, similar reports in patients with ET are scant in the current literature. Louis et al. 17 prospectively studied the relationship between selfreported depression at baseline and the risk of incident ET in the NEDICES cohort. In this longitudinal study, baseline self-reported depression and baseline self-reported use of antidepressants were each associated with incident ET (respective relative risks 5 1.78 and 1.90). These data suggest that depression may be part of the primary disease process in ET rather than a response to the presence and disabling effects of tremor. This idea gains additional support from studies that did not detect a correlation between the severity of depression and the severity of tremor in patients with ET. 18, 19 Aside from this study of the NEDICES cohort, one retrospective study documented the presence of neuropsychiatric symptoms prior to the index date (date on which a diagnosis of ET was made). 20 In this 45-year retrospective study in Rochester, Minnesota, the authors documented the presence of psychoneurosis in 16% of ET cases prior to the index date. However, details regarding the nature and onset of ''psychoneurosis'' were not explicitly described nor were control data reported in order to interpret whether the prevalence in ET cases was elevated above and beyond normal levels. 
Sleep dysregulation as a premotor symptom
Although sleep disturbances like RBD has been established as a premotor symptom in PD and other synucleinopathies such as multiple system atrophy and dementia with Lewy bodies (LB), there is little information about premotor sleep dysregulation in ET. Cross-sectional studies have furnished mixed evidence regarding sleep disturbances in ET 14, 21, 22 although the majority suggest that there is a problem, 2 and several studies 22, 23 have reported that sleep quality scores in ET fall intermediately between patients with PD and healthy controls. However, it is difficult to ascertain if the sleep disturbances occur before or after the onset of tremor. Normal sleep is regulated through a coordinated expression of several neurotransmitters in the brainstem and hypothalamic neurons. In this context, it is important to note that the neuropathological investigations have revealed the presence of LB in brainstem structures especially in the locus coeruleus in the brains of some ET patients. 24, 25 As the premotor symptoms in PD (RBD, olfactory dysfunction, constipation, depression) have been speculated to be the result of caudo-cranial progression of LB deposition, which usually begins in the olfactory bulb and subsequently involves the brainstem structures, 26 it is possible that as in PD the LB deposition in some of the ET patients begins before the onset of tremor and perhaps contributes towards a few of the NMS such as sleep dysregulation. Currently we are aware of only one study that prospectively studied the relationship between sleep duration and ET. 27 In this study by Benito-León et al., 27 3,303 participants were followed up for a median duration of 3.3 years during which 76 subjects developed incident ET. Interestingly, participants who reported short duration of sleep (#5 hours/day) at baseline had a higher risk of developing incident ET. The results of this study raise two possibilities -either short sleep duration is a premotor symptom of ET or short sleep duration is a risk factor for ET. Considering the fact that there are no biologically plausible explanations for a cause-and-effect relationship of short sleep duration and risk of ET, the short sleep duration is more likely to represent a premotor symptom of ET. Nonetheless, more studies are warranted in order to develop a more conclusive picture of the role of sleep dysregulation in the natural course of ET. Reports of RBD, which is an established premotor feature of PD, are rare in patients with ET. In a recently published abstract, Barbosa et al. 28 reported the presence of RBD in 26.4% patients with ET and those ET patients with RBD had more autonomic dysfunction compared to those without RBD. As such a high prevalence of RBD has never been reported in patients with ET before, further studies need to confirm this finding and place it within the context of control data.
Restless legs syndrome
Restless legs syndrome (RLS) is a comorbidity in several neurological disorders including PD, ET, and Tourette syndrome. [29] [30] [31] In fact, many patients with PD have RLS before the onset of motor symptoms. In a large prospective study of US veterans with a median follow-up time of 7.8 years, individuals with prevalent RLS had a twofold higher risk of incident PD than did individuals without RLS. 32 Another prospective population-based study of US health professionals has also revealed higher rates of incident PD in subjects having severe prevalent RLS. 33 These large population based prospective studies suggest that RLS is a premotor symptom of PD. There are fewer epidemiological studies on RLS in ET. In a study by Wu et al., which estimated the prevalence of ET and its NMS in a rural population in Shanghai, China, the prevalence of RLS was significantly higher in ET cases compared to healthy controls. 34 However, as it was a cross sectional study, the natural course of RLS in ET was not clear. Ondo and Lai 30 reported the presence of RLS in 33% of their ET patients who were consecutively evaluated; however, no control group was enrolled for comparison. Conversely none of the 68 consecutive patients with RLS who were recruited during the same time in this study had overtly pathological tremor amounting to a diagnosis of ET.
To the best of our knowledge, there is only one case report that described the onset of RLS (childhood) much earlier than the onset of tremor (teen age) in a patient with ET. 35 Prospective studies are warranted to gain better insights into the complex relationship between ET and RLS.
Premorbid personality in ET
Personality traits are defined as the relatively enduring patterns of thoughts, feelings, and behaviors that distinguish individuals from one another. 36 As personality traits may remain stable for a fair amount of time in a person's life, traits (if premorbid) specific to a disease can be speculated to be a component of the premotor spectrum. Several studies have assessed personality traits in patients with movement disorders such as PD, HD, and ET. We are aware of three crosssectional studies on patients with ET in which personality traits were compared with healthy controls. [37] [38] [39] In the studies by Chaterjee et al. 37 and Thenganatt et al., 38 the Tridimensional Personality Questionnaire (TPQ) was used to assess the personality traits and in both these studies patients with ET scored higher in the harm avoidance (HA) subscales. A high score on the HA subscale indicates that the person is pessimistic, fearful, shy, anxious, and is easily fatigued. Lorenz et al. 39 used a revised version of the Eyesenck Personality Questionnaire (EPQ-R) to assess the personality traits in German patients with ET. The EPQ-R measures three dimensions of personality: extraversion (E), neuroticism (N), and psychoticism (P).
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In this study, the authors reported a significantly lower score on the P-scale, suggesting that ET patients are kinder, more tender-minded, and less aggressive than the normal population. Considering the crosssectional design of the study, it is difficult to ascertain whether the personality trait observed by Lorenz et al. was premorbid personality or it was the psychological response to the tremor of ET. However, there is evidence that suggests that the traits represented on the Eysenck's P-scale are heritable 41, 42 and they may have direct 43, 44 or indirect association 45 with androgen action. This information suggests that low P-score is a premorbid personality in ET, rather than an epiphenomenon. As the complex interplay between testosterone and serotonin may affect aggression, fear and anxiety in a person, 45, 46 the results of the studies by Chatterjee et al. 37 and Thenganatt et al. 38 also appear to favor a premorbid personality in ET rather than secondary response to tremor, the reason being the personality dimensions of the TPQ have been associated with changes in neurotransmitter activity as the patients with high HA scores have increased 5-Hydroxytryptamine (5-HT) release from presynaptic neurons after the administration of serotonergic agonists. 47 
Clues from olfactory dysfunction
Olfactory dysfunction (hyposmia/anosmia) is an established premotor symptom of PD. 6, 48 However, the literature on olfactory dysfunction in ET remains controversial as studies have either reported no olfactory dysfunction [49] [50] [51] [52] or greater dysfunction [53] [54] [55] in patients with ET compared to controls. In one of the studies reporting olfactory dysfunction in ET, the degree of deficit was unrelated to the severity of tremor and duration. 53 Similar results (no correlation with disease stage and severity) have been described in the context of olfactory deficits in PD. 56 This implies olfactory deficits, when present, are perhaps parts of the primary disease process rather being a secondary response.
Hypotheses for the premotor phase
To date, the bulk of evidence that favors the existence of a premotor phase of ET is derived from the studies on the NEDICES cohort. In individuals who develop incident ET, baseline (i.e., premotor) evaluations reveal greater cognitive dysfunction, a faster rate of cognitive decline, and the presence of a protective effect of education against dementia. In addition, in these same individuals, baseline (i.e., premotor) evaluations reveal more self-reported depression and antidepressant medication use, and shorter sleep duration. These data are the suggestive evidence of the existence of a premotor phase of ET (Figure 2 ). In addition, certain personality traits and NMS such as RLS and possible olfactory dysfunction, which have long been regarded as premotor symptoms of PD, also provide some evidence that a premotor phase exists in ET (Figure 2) . From the point of view of the disease pathophysiology, there is biological support for this notion. As described above, the neuropathological investigations have revealed LB deposition in several regions of the brain of ET patients in some studies. It is very much possible that similar to PD, the natural course of certain NMS may follow the degree and distribution of the LB in the brain. Numerous structural and functional neuroimaging studies have explored the neural correlates of ET. 57, 58 Although alteration in the components of the cerebello-thalamo-cortical network has been the major result across the imaging studies, [59] [60] [61] [62] several studies have also noted abnormalities in structures that do not have any apparent role in genesis of tremor. For example, the functional neuroimaging studies by Benito-León et al. 61 and Fang et al. 63 have revealed altered connectivity in multiple resting state brain networks (default mode network, fronto-parietal network, visual network), which are presumed to regulate various cognitive processes. Similarly the structural neuroimaging studies by Bhalsing et al., which were aimed at comparing the gray 64 and white matter 65 microstructural changes in ET patients with and without cognitive impairment, have revealed structural alterations in several regions of brain (reduced gray matter volume in the medial frontal gyrus, postcentral gyrus, insula, cingulate, and white matter changes in frontal cortex, cingulate, superior and inferior longitudinal fasciculus) that have not been described to play any role in the genesis of tremor in ET. These data suggest that the disease pathology in ET is not limited only to the motor network, but, rather, it is possible that multiple structures or networks may be involved in parallel. In other words, ET may be a neurodegenerative disorder with alteration of several neural networks. It is possible that the beginning of alterations in certain networks predates the alterations of other networks. Hence if the alteration in networks or structures that theoretically correspond to a NMS occur earlier than alterations in the motor network, the patient will have the respective NMS as a premotor symptom.
Conclusion
To summarize, although limited in number, there is some current evidence that suggests the existence of a premotor phase of ET. As a majority of the evidence is from studies involving the NEDICES cohort, more population-based longitudinal studies are crucial for further characterization of the premotor phase of ET. In this context, individuals who are at higher risk of developing ET (i.e., unaffected first-degree relatives of ET patients) appear to be an ideal population for the future longitudinal studies in order to gain more insights into the premotor phase of ET (Table 2) ; no data on the prevalence of non-motor symptoms in these at-risk relatives have been published.
